ANGO three-lens brief
Evidence-based stock research on ANGO. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA above 200-day MA (golden-cross regime); price above both. · Currently unprofitable on a trailing basis — no P/E multiple available.
- 50-day MA above 200-day MA (golden-cross regime); price above both.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $20.00 — 31% above current (4 analysts).
- Earnings scheduled 2026-10-01.
ANGO closed at $15.24 (-0.52%) as of 2026-09-11. Market cap: $629.91M. Price is above the 50-day MA and above the 200-day MA. Positives: 50-day MA above 200-day MA (golden-cross regime); price above both.; analyst mean target $20.00 — 31% above current (4 analysts).. Concerns: currently unprofitable on a trailing basis — no P/E multiple available.. Last quarter: Revenue $86.61M, net income -$11.40M, free cash flow $21.77M. Watching for: 2026-10-01 earnings release (20 days out).
Why three lenses on ANGO, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ANGOacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ANGO" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ANGO brief"></iframe>